[1]
Tayyaba Rafiq, Raima Kalhoro, Abdul Rehman Khalil Shaikh, Furqan Ahmed Bhatti, Haseeb Khaliq, and Akram Ali, “THE PROGNOSTIC SIGNIFICANCE OF PD-L1 EXPRESSION IN IMMUNE CHECKPOINT THERAPY FOR DIVERSITY IN HEAD AND NECK TUMORS ASSESSMENTS, INSIGHTS TO MOLECULAR ONCOLOGY THERAPEUTICS”, J Popl Ther Clin Pharmacol, vol. 31, no. 8, pp. 3453–3459, Aug. 2024, doi: 10.53555/gh4hse49.